Stephen O’Quinn

2.0k total citations
28 papers, 1.5k citations indexed

About

Stephen O’Quinn is a scholar working on Psychiatry and Mental health, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, Stephen O’Quinn has authored 28 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Psychiatry and Mental health, 17 papers in Physiology and 15 papers in Pathology and Forensic Medicine. Recurrent topics in Stephen O’Quinn's work include Migraine and Headache Studies (21 papers), Sympathectomy and Hyperhidrosis Treatments (15 papers) and Trigeminal Neuralgia and Treatments (14 papers). Stephen O’Quinn is often cited by papers focused on Migraine and Headache Studies (21 papers), Sympathectomy and Hyperhidrosis Treatments (15 papers) and Trigeminal Neuralgia and Treatments (14 papers). Stephen O’Quinn collaborates with scholars based in United States, United Kingdom and Australia. Stephen O’Quinn's co-authors include Richard B. Lipton, Roger Cady, Donna Gutterman, Charles B. Hall, Walter F. Stewart, Timothy A. Kuhn, Scott McNeal, Carolyn Watson, Fred D. Sheftell and Alice S. Batenhorst and has published in prestigious journals such as Biological Psychiatry, Journal of the American Academy of Child & Adolescent Psychiatry and Mayo Clinic Proceedings.

In The Last Decade

Stephen O’Quinn

27 papers receiving 1.4k citations

Peers

Countries citing papers authored by Stephen O’Quinn

Since Specialization

Citations

This map shows the geographic impact of Stephen O’Quinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen O’Quinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen O’Quinn more than expected).

Fields of papers citing papers by Stephen O’Quinn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen O’Quinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen O’Quinn. The network helps show where Stephen O’Quinn may publish in the future.

Co-authorship network of co-authors of Stephen O’Quinn

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen O’Quinn. A scholar is included among the top collaborators of Stephen O’Quinn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen O’Quinn. Stephen O’Quinn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An exploratory analysis of bezisterim treatment associated with decreased biological age acceleration, and improved clinical measure and biomarker changes in mild-to-moderate probable Alzheimer's disease 2025 ·Frontiers in Neuroscience ·Christopher L. Reading, Jiayan Yan, Marcia A. Testa, Donald C. Simonson, (unknown), (unknown), Daniel E. Martin‐Herranz, Robert T. Brooke, Juozas Gordevičius, Jeffrey Zhang, (unknown), Clarence Ahlem, Lixia Wang, (unknown), Noor Azuan Abu Osman, Stephen O’Quinn, Joseph Palumbo	1
2	Long-term safety and tolerability of transdermal cannabidiol gel in children and adolescents with Fragile X syndrome (ZYN2-CL-017): an interim analysis of an ongoing open-label extension study 2025 ·Journal of Neurodevelopmental Disorders ·Elizabeth Berry‐Kravis, Randi J. Hagerman, Jonathan Cohen, Dejan B. Budimirovic, (unknown), Natalie Silove, (unknown), (unknown), (unknown), Terri Sebree, Stephen O’Quinn, David S. Albers, (unknown), George G. Nomikos, (unknown)	0
3	Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment 2023 ·Journal of Neurodevelopmental Disorders ·Joseph Palumbo, Brian F. Thomas, Dejan B. Budimirovic, Steven J. Siegel, Flora Tassone, Randi J. Hagerman, Christopher Faulk, Stephen O’Quinn, Terri Sebree	13
4	A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX) 2022 ·Journal of Neurodevelopmental Disorders ·Elizabeth Berry‐Kravis, Randi J. Hagerman, Dejan B. Budimirovic, Craig A. Erickson, Helen Heussler, Nicole Tartaglia, Jonathan Cohen, Flora Tassone, (unknown), Elizabeth Merikle, Terri Sebree, (unknown), Joseph Palumbo, Stephen O’Quinn	39
5	Pain-Free Results With Sumatriptan Taken at the First Sign of Migraine Pain: 2 Randomized, Double-Blind, Placebo-Controlled Studies 2003 ·Mayo Clinic Proceedings ·Paul Winner, Lisa K. Mannix, (unknown), Scott McNeal, (unknown), Stephen O’Quinn, Mary S. Richardson	74
6	The pharmacokinetics of sumatriptan when administered with clarithromycin in healthy volunteers 2002 ·Clinical Therapeutics ·Katy H. P. Moore, Philip T. Leese, Scott McNeal, Peter P. Gray, Stephen O’Quinn, Carole Bye, Mark Sale	15
7	Naratriptan as Short‐Term Prophylaxis of Menstrually Associated Migraine: A Randomized, Double‐Blind, Placebo‐Controlled Study 2001 ·Headache The Journal of Head and Face Pain ·Lawrence C. Newman, (unknown), Stephen H. Landy, SD Silberstein, Richard B. Lipton, (unknown), Carolyn Watson, Maria M. Jöbsis, Alice S. Batenhorst, Stephen O’Quinn	135
8	Economic implications of early treatment of migraine with sumatriptan tablets 2001 ·Clinical Therapeutics ·Roger Cady, Fred D. Sheftell, Richard B. Lipton, Winghan Jacqueline Kwong, Stephen O’Quinn	23
9	Sumatriptan Nasal Spray and Cognitive Function During Migraine: Results of an Open‐Label Study 2001 ·Headache The Journal of Head and Face Pain ·Kathleen Farmer, Roger Cady, Joseph Bleiberg, Dennis Reeves, (unknown), Stephen O’Quinn, Alice S. Batenhorst	54
10	Effects of encapsulation on absorption of sumatriptan tablets: data from healthy volunteers and patients during a migraine 2001 ·Clinical Therapeutics ·Eliane Fuseau, Olivier Pétricoul, (unknown), Adrian Pereira, Stephen O’Quinn, Stephen Thein, Mark Leibowitz, (unknown), Scott McNeal, R Salonen, Alan Metz, Peter E. Coates	31
11	Joint Responses From Lipton et al and Cady et al 2001 ·Headache The Journal of Head and Face Pain ·Richard B. Lipton, Walter F. Stewart, Roger Cady, Charles A. S. Hall, Stephen O’Quinn, Timothy Kuhn, Donna Gutterman	1
12	Response From Cady et al 2001 ·Headache The Journal of Head and Face Pain ·Roger Cady, Richard B. Lipton, Charles B. Hall, Walter F. Stewart, Stephen O’Quinn, Donna Gutterman	1
13	Effectiveness of Sumatriptan in Reducing Productivity Loss Due to Migraine: Results of a Randomized, Double-Blind, Placebo-Controlled Clinical Trial 2000 ·Mayo Clinic Proceedings ·(unknown), Roger Cady, Dan Henry, Alice S. Batenhorst, (unknown), Carolyn Watson, Stephen O’Quinn	64
14	Low Migraine Headache Recurrence With Naratriptan: Clinical Parameters Related to Recurrence 2000 ·Headache The Journal of Head and Face Pain ·Fred D. Sheftell, Stephen O’Quinn, Carolyn Watson, (unknown), P D Winter	33
15	Sumatriptan for the Range of Headaches in Migraine Sufferers: Results of the Spectrum Study 2000 ·Headache The Journal of Head and Face Pain ·Richard B. Lipton, Walter F. Stewart, (unknown), Charles B. Hall, Stephen O’Quinn, Timothy A. Kuhn, Donna Gutterman	178
16	Treatment of Mild Headache in Disabled Migraine Sufferers: Results of the Spectrum Study 2000 ·Headache The Journal of Head and Face Pain ·Roger Cady, Richard B. Lipton, Charles B. Hall, Walter F. Stewart, Stephen O’Quinn, Donna Gutterman	157
17	Naratriptan Efficacy in Migraineurs Who Respond Poorly to Oral Sumatriptan 2000 ·Headache The Journal of Head and Face Pain ·Stuart R. Stark, Egilius L.H. Spierings, Scott McNeal, (unknown), Carolyn Watson, Stephen O’Quinn	61
18	Effect of early intervention with sumatriptan on migraine pain: Retrospective analyses of data from three clinical trials 2000 ·Clinical Therapeutics ·Roger Cady, Fred D. Sheftell, Richard B. Lipton, Stephen O’Quinn, Martin Jones, (unknown), Adam Crisp, Alan Metz, Scott McNeal	182
19	Pregnancy and perinatal outcomes in migraineurs using sumatriptan: a prospective study 1999 ·Archives of Gynecology and Obstetrics ·Stephen O’Quinn, Sara A. Ephross, Vanessa C. Williams, R. L. Davis, Donna Gutterman, Anthony W. Fox	45
20	Sumatriptan Injection Reduces Productivity Loss During a Migraine Attack 1998 ·Archives of Internal Medicine ·(unknown), Richella Ryan, (unknown), Stephen O’Quinn, (unknown)	87

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact